Literature DB >> 15856335

Efficacy of progressive muscle relaxation training and guided imagery in reducing chemotherapy side effects in patients with breast cancer and in improving their quality of life.

Hee J Yoo1, Se H Ahn, Sung B Kim, Woo K Kim, Oh S Han.   

Abstract

GOALS: This study was designed to assess the effectiveness of progressive muscle relaxation training (PMRT) and guided imagery (GI) in reducing the anticipatory nausea and vomiting (ANV) and postchemotherapy nausea and vomiting (PNV) of patients with breast cancer and to measure their effects on the patients' quality of life (QoL). PATIENTS AND METHODS: Thirty chemotherapy-naive patients with breast cancer were randomized to the PMRT and GI group and 30 to the control group. Before each of six cycles of adjuvant chemotherapy, each patient was administered a self-report Multiple Affect Adjective Checklist (MAACL), and incidents of ANV and PNV for the first three postchemotherapy days were recorded. All patients were administered the Functional Assessment of Cancer Therapy-Breast (FACT-B) at baseline and after 3 and 6 months.
RESULTS: We found that the PMRT and GI group was significantly less anxious, depressive, and hostile than the control group. We also found that the PMRT and GI group experienced significantly less ANV and PNV and that 6 months after CT, the QoL of the PMRT and GI group was higher than that of the control group.
CONCLUSION: These results indicate that PMRT and GI were associated with both the improvements in ANV and PNV and in the QoL of patients with breast cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15856335     DOI: 10.1007/s00520-005-0806-7

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  26 in total

1.  A power primer.

Authors:  J Cohen
Journal:  Psychol Bull       Date:  1992-07       Impact factor: 17.737

2.  Efficacy of relaxation training and guided imagery in reducing the aversiveness of cancer chemotherapy.

Authors:  J N Lyles; T G Burish; M G Krozely; R K Oldham
Journal:  J Consult Clin Psychol       Date:  1982-08

3.  Hypnotic control of anticipatory emesis in patients receiving cancer chemotherapy.

Authors:  W H Redd; G V Andresen; R Y Minagawa
Journal:  J Consult Clin Psychol       Date:  1982-02

4.  Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument.

Authors:  M J Brady; D F Cella; F Mo; A E Bonomi; D S Tulsky; S R Lloyd; S Deasy; M Cobleigh; G Shiomoto
Journal:  J Clin Oncol       Date:  1997-03       Impact factor: 44.544

5.  Psychological factors can predict the response to primary chemotherapy in patients with locally advanced breast cancer.

Authors:  L G Walker; S D Heys; M B Walker; K Ogston; I D Miller; A W Hutcheon; T K Sarkar; A K Ah-See; O Eremin
Journal:  Eur J Cancer       Date:  1999-12       Impact factor: 9.162

6.  Quality of life and quality adjusted survival for breast cancer patients receiving adjuvant therapy. Eastern Cooperative Oncology Group (ECOG).

Authors:  D L Fairclough; J H Fetting; D Cella; W Wonson; C M Moinpour
Journal:  Qual Life Res       Date:  1999-12       Impact factor: 4.147

7.  Pretreatment factors predicting the development of postchemotherapy nausea and vomiting in Chinese breast cancer patients.

Authors:  A Molassiotis; B M C Yam; H Yung; F Y S Chan; T S K Mok
Journal:  Support Care Cancer       Date:  2001-11-20       Impact factor: 3.603

8.  Determinants of postchemotherapy nausea and vomiting in patients with cancer. Quality of Life and Symptom Control Committees of the National Cancer Institute of Canada Clinical Trials Group.

Authors:  D Osoba; B Zee; J Pater; D Warr; J Latreille; L Kaizer
Journal:  J Clin Oncol       Date:  1997-01       Impact factor: 44.544

Review 9.  Symptom control in psychosocial oncology.

Authors:  T G Burish; W H Redd
Journal:  Cancer       Date:  1994-08-15       Impact factor: 6.860

10.  A daily diary for quality of life measurement in advanced breast cancer trials.

Authors:  S C Fraser; A J Ramirez; S R Ebbs; L J Fallowfield; H J Dobbs; M A Richards; T Bates; M Baum
Journal:  Br J Cancer       Date:  1993-02       Impact factor: 7.640

View more
  23 in total

1.  Effect of virtual reality on time perception in patients receiving chemotherapy.

Authors:  Susan M Schneider; Cassandra K Kisby; Elizabeth P Flint
Journal:  Support Care Cancer       Date:  2010-03-26       Impact factor: 3.603

Review 2.  Clinical practice guidelines on the use of integrative therapies as supportive care in patients treated for breast cancer.

Authors:  Heather Greenlee; Lynda G Balneaves; Linda E Carlson; Misha Cohen; Gary Deng; Dawn Hershman; Matthew Mumber; Jane Perlmutter; Dugald Seely; Ananda Sen; Suzanna M Zick; Debu Tripathy
Journal:  J Natl Cancer Inst Monogr       Date:  2014-11

Review 3.  Anticipatory nausea and vomiting due to chemotherapy.

Authors:  Charles Kamen; Mohamedtaki A Tejani; Kavita Chandwani; Michelle Janelsins; Anita R Peoples; Joseph A Roscoe; Gary R Morrow
Journal:  Eur J Pharmacol       Date:  2013-10-21       Impact factor: 4.432

Review 4.  Anticipatory nausea and vomiting.

Authors:  Joseph A Roscoe; Gary R Morrow; Matti S Aapro; Alexander Molassiotis; Ian Olver
Journal:  Support Care Cancer       Date:  2010-08-30       Impact factor: 3.603

Review 5.  Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment.

Authors:  Heather Greenlee; Melissa J DuPont-Reyes; Lynda G Balneaves; Linda E Carlson; Misha R Cohen; Gary Deng; Jillian A Johnson; Matthew Mumber; Dugald Seely; Suzanna M Zick; Lindsay M Boyce; Debu Tripathy
Journal:  CA Cancer J Clin       Date:  2017-04-24       Impact factor: 508.702

6.  Alleviation of Side Effects and Distress in Breast Cancer Patients by Cognitive-Behavioral Interventions: A Systematic Review and Meta-analysis.

Authors:  Oana Cobeanu; Daniel David
Journal:  J Clin Psychol Med Settings       Date:  2018-12

7.  Forming a Stress Management and Health Promotion Program for Women Undergoing Chemotherapy for Breast Cancer: A Pilot Randomized Controlled Trial.

Authors:  Panagiotis Pelekasis; Georgia Zisi; Anna Koumarianou; Androniki Marioli; George Chrousos; Konstantinos Syrigos; Christina Darviri
Journal:  Integr Cancer Ther       Date:  2015-08-04       Impact factor: 3.279

Review 8.  The impact of clinical and sociodemographic features on quality of life in patients with early stage cancers using the Functional Assessment of Cancer Therapy-General assessment tool.

Authors:  Marko Popovic; Nicholas Lao; Liang Zeng; Liying Zhang; David Cella; Jennifer L Beaumont; Ronald Chow; Nicholas Chiu; Leonard Chiu; Henry Lam; Michael Poon; Edward Chow
Journal:  Support Care Cancer       Date:  2013-03-22       Impact factor: 3.603

9.  Patient-Reported Outcomes From Phase III Neoadjuvant Systemic Trial Comparing Neoadjuvant Chemotherapy With Neoadjuvant Endocrine Therapy in Pre-Menopausal Patients With Estrogen Receptor-Positive and HER2-Negative, Lymph Node-Positive Breast Cancer.

Authors:  Sungchan Gwark; Sei Hyun Ahn; Woo Chul Noh; Eun Sook Lee; Yongsik Jung; Lee Su Kim; Wonshik Han; Seok Jin Nam; Gyungyub Gong; Seon-Ok Kim; Hee Jeong Kim
Journal:  Front Oncol       Date:  2021-07-02       Impact factor: 6.244

10.  The effects of relaxation on reducing depression, anxiety and stress in women who underwent mastectomy for breast cancer.

Authors:  Fahimeh Kashani; Sima Babaee; Masoud Bahrami; Mahboobeh Valiani
Journal:  Iran J Nurs Midwifery Res       Date:  2012-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.